EXEL Exelixis Inc

Exelixis Inc is a part of the healthcare sector. As a biotechnology company, it develops small molecule therapies for the treatment of cancer.

$23.44  +0.41 (1.76%)
As of 04/13/2021 15:59:46 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/15/2001
Outstanding shares:  311,989,661
Average volume:  1,822,738
Market cap:   $7,185,121,893
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    30161Q104
ISIN:        US30161Q1040
Sedol:      2576941
Valuation   (See tab for details)
PE ratio:   75.47
PB ratio:   3.82
PS ratio:   0.00
Return on equity:   5.41%
Net income %:   5.85%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy